Related Experiment Video
Updated: Sep 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality
Marko Baralić1,2, Nikola Stojanović3, Selena Gajić2
1Faculty of Medicine, University of Belgrade, Dr. Subotića Starijeg Str. 8, 11000 Belgrade, Serbia.
Patients on peritoneal dialysis (PD) have weakened immune responses to SARS-CoV-2. Tailored COVID-19 vaccination strategies and telemedicine are crucial for improving outcomes in this vulnerable group.
Area of Science:
- Immunology
- Nephrology
- Infectious Diseases
Background:
- Patients on peritoneal dialysis (PD) exhibit inherent immune dysfunction and comorbidities, increasing vulnerability to infections.
- SARS-CoV-2 poses a significant threat to PD patients, necessitating a thorough understanding of their immune responses.
Purpose of the Study:
- To review the immunological response to SARS-CoV-2 in peritoneal dialysis patients.
- To assess the efficacy of different COVID-19 vaccine platforms and booster strategies in this population.
- To explore the role of PD as a home-based dialysis modality in mitigating infection risk.
Main Methods:
- Literature review focusing on viral entry, immune activation, and evasion mechanisms in PD patients.
- Critical assessment of immunogenicity and clinical efficacy data for various vaccine platforms (inactivated, vector-based, mRNA).
- Evaluation of the impact of waning immunity, viral variants, and booster doses on vaccine effectiveness.
Main Results:
- PD patients demonstrate impaired cellular and humoral immune responses to SARS-CoV-2, including reduced T-cell function and antibody production.
- Vaccine platforms show variable efficacy, with booster doses being essential for sustained protection against evolving variants.
- Peritoneal dialysis offers advantages like home-based care and telemedicine compatibility, potentially reducing viral exposure risks.
Conclusions:
- Individualized vaccination strategies, including tailored booster doses, are vital for optimizing protection in PD patients.
- Close immunological surveillance and innovative dialysis care models are necessary to improve clinical outcomes.
- Integrating telemedicine into PD care can enhance patient management and reduce exposure during public health crises.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

